Logo image of CBZ

CBIZ INC (CBZ) Stock Fundamental Analysis

NYSE:CBZ - New York Stock Exchange, Inc. - US1248051021 - Common Stock - Currency: USD

73.76  +1.32 (+1.82%)

After market: 73.76 0 (0%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CBZ. CBZ was compared to 81 industry peers in the Professional Services industry. CBZ has a medium profitability rating, but doesn't score so well on its financial health evaluation. CBZ is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year CBZ was profitable.
In the past year CBZ had a positive cash flow from operations.
In the past 5 years CBZ has always been profitable.
In the past 5 years CBZ always reported a positive cash flow from operatings.
CBZ Yearly Net Income VS EBIT VS OCF VS FCFCBZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

The Return On Assets of CBZ (1.90%) is comparable to the rest of the industry.
CBZ has a Return On Equity of 4.54%. This is comparable to the rest of the industry: CBZ outperforms 45.68% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.10%, CBZ is in line with its industry, outperforming 45.68% of the companies in the same industry.
CBZ had an Average Return On Invested Capital over the past 3 years of 6.53%. This is significantly below the industry average of 12.53%.
Industry RankSector Rank
ROA 1.9%
ROE 4.54%
ROIC 4.1%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
CBZ Yearly ROA, ROE, ROICCBZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CBZ has a Profit Margin (4.03%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CBZ has declined.
The Operating Margin of CBZ (10.37%) is better than 76.54% of its industry peers.
CBZ's Operating Margin has declined in the last couple of years.
With a Gross Margin value of 13.80%, CBZ is not doing good in the industry: 81.48% of the companies in the same industry are doing better.
CBZ's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.37%
PM (TTM) 4.03%
GM 13.8%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
CBZ Yearly Profit, Operating, Gross MarginsCBZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CBZ is destroying value.
The number of shares outstanding for CBZ has been increased compared to 1 year ago.
CBZ has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CBZ has a worse debt to assets ratio.
CBZ Yearly Shares OutstandingCBZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
CBZ Yearly Total Debt VS Total AssetsCBZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

An Altman-Z score of 1.93 indicates that CBZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 1.93, CBZ is not doing good in the industry: 61.73% of the companies in the same industry are doing better.
The Debt to FCF ratio of CBZ is 17.74, which is on the high side as it means it would take CBZ, 17.74 years of fcf income to pay off all of its debts.
CBZ has a Debt to FCF ratio of 17.74. This is in the lower half of the industry: CBZ underperforms 65.43% of its industry peers.
CBZ has a Debt/Equity ratio of 0.76. This is a neutral value indicating CBZ is somewhat dependend on debt financing.
CBZ's Debt to Equity ratio of 0.76 is on the low side compared to the rest of the industry. CBZ is outperformed by 61.73% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 17.74
Altman-Z 1.93
ROIC/WACC0.52
WACC7.88%
CBZ Yearly LT Debt VS Equity VS FCFCBZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

CBZ has a Current Ratio of 1.52. This is a normal value and indicates that CBZ is financially healthy and should not expect problems in meeting its short term obligations.
CBZ's Current ratio of 1.52 is in line compared to the rest of the industry. CBZ outperforms 53.09% of its industry peers.
A Quick Ratio of 1.52 indicates that CBZ should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.52, CBZ is in line with its industry, outperforming 56.79% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.52
Quick Ratio 1.52
CBZ Yearly Current Assets VS Current LiabilitesCBZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

9

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 34.41% over the past year.
Measured over the past years, CBZ shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.05% on average per year.
The Revenue has grown by 32.27% in the past year. This is a very strong growth!
The Revenue has been growing by 13.84% on average over the past years. This is quite good.
EPS 1Y (TTM)34.41%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%49.67%
Revenue 1Y (TTM)32.27%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%69.54%

3.2 Future

The Earnings Per Share is expected to grow by 26.87% on average over the next years. This is a very strong growth
CBZ is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 30.84% yearly.
EPS Next Y41.11%
EPS Next 2Y26.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year61.9%
Revenue Next 2Y30.84%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CBZ Yearly Revenue VS EstimatesCBZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B
CBZ Yearly EPS VS EstimatesCBZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 22.22, which indicates a rather expensive current valuation of CBZ.
Compared to the rest of the industry, the Price/Earnings ratio of CBZ is on the same level as its industry peers.
CBZ's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.45.
The Price/Forward Earnings ratio is 17.90, which indicates a rather expensive current valuation of CBZ.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CBZ is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.90, CBZ is valued at the same level.
Industry RankSector Rank
PE 22.22
Fwd PE 17.9
CBZ Price Earnings VS Forward Price EarningsCBZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CBZ is on the same level as its industry peers.
The rest of the industry has a similar Price/Free Cash Flow ratio as CBZ.
Industry RankSector Rank
P/FCF 46.56
EV/EBITDA 19.27
CBZ Per share dataCBZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CBZ's earnings are expected to grow with 26.87% in the coming years.
PEG (NY)0.54
PEG (5Y)1.48
EPS Next 2Y26.87%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CBZ!.
Industry RankSector Rank
Dividend Yield N/A

CBIZ INC

NYSE:CBZ (7/3/2025, 7:07:53 PM)

After market: 73.76 0 (0%)

73.76

+1.32 (+1.82%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)04-24 2025-04-24/bmo
Earnings (Next)07-24 2025-07-24/bmo
Inst Owners83.3%
Inst Owner Change-1.43%
Ins Owners3.45%
Ins Owner Change-0.95%
Market Cap4.01B
Analysts85.71
Price Target96.9 (31.37%)
Short Float %5.18%
Short Ratio5.29
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)12.56%
Min EPS beat(2)7.63%
Max EPS beat(2)17.49%
EPS beat(4)3
Avg EPS beat(4)-2.12%
Min EPS beat(4)-43.49%
Max EPS beat(4)17.49%
EPS beat(8)6
Avg EPS beat(8)-1.43%
EPS beat(12)9
Avg EPS beat(12)2.47%
EPS beat(16)12
Avg EPS beat(16)1.07%
Revenue beat(2)1
Avg Revenue beat(2)4.27%
Min Revenue beat(2)-3.55%
Max Revenue beat(2)12.08%
Revenue beat(4)1
Avg Revenue beat(4)1.3%
Min Revenue beat(4)-3.55%
Max Revenue beat(4)12.08%
Revenue beat(8)4
Avg Revenue beat(8)1.65%
Revenue beat(12)8
Avg Revenue beat(12)3.22%
Revenue beat(16)12
Avg Revenue beat(16)3.91%
PT rev (1m)0%
PT rev (3m)-3.55%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-13.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-1.11%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-4.44%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-2.47%
Valuation
Industry RankSector Rank
PE 22.22
Fwd PE 17.9
P/S 1.86
P/FCF 46.56
P/OCF 40.47
P/B 2.1
P/tB N/A
EV/EBITDA 19.27
EPS(TTM)3.32
EY4.5%
EPS(NY)4.12
Fwd EY5.59%
FCF(TTM)1.58
FCFY2.15%
OCF(TTM)1.82
OCFY2.47%
SpS39.65
BVpS35.2
TBVpS-18.23
PEG (NY)0.54
PEG (5Y)1.48
Profitability
Industry RankSector Rank
ROA 1.9%
ROE 4.54%
ROCE 5.7%
ROIC 4.1%
ROICexc 4.11%
ROICexgc 15.92%
OM 10.37%
PM (TTM) 4.03%
GM 13.8%
FCFM 3.99%
ROA(3y)4.15%
ROA(5y)4.39%
ROE(3y)10.79%
ROE(5y)10.71%
ROIC(3y)6.53%
ROIC(5y)6.32%
ROICexc(3y)6.56%
ROICexc(5y)6.34%
ROICexgc(3y)21.85%
ROICexgc(5y)20.77%
ROCE(3y)9.09%
ROCE(5y)8.79%
ROICexcg growth 3Y-18.93%
ROICexcg growth 5Y-6.45%
ROICexc growth 3Y-27.55%
ROICexc growth 5Y-15.96%
OM growth 3Y-10.26%
OM growth 5Y-4.48%
PM growth 3Y-29.35%
PM growth 5Y-21.21%
GM growth 3Y-10.5%
GM growth 5Y-4.73%
F-Score3
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 0.76
Debt/FCF 17.74
Debt/EBITDA 5.09
Cap/Depr 20.46%
Cap/Sales 0.6%
Interest Coverage 250
Cash Conversion 34.53%
Profit Quality 99.14%
Current Ratio 1.52
Quick Ratio 1.52
Altman-Z 1.93
F-Score3
WACC7.88%
ROIC/WACC0.52
Cap/Depr(3y)38.86%
Cap/Depr(5y)40%
Cap/Sales(3y)0.92%
Cap/Sales(5y)0.96%
Profit Quality(3y)163.09%
Profit Quality(5y)166.86%
High Growth Momentum
Growth
EPS 1Y (TTM)34.41%
EPS 3Y16%
EPS 5Y15.05%
EPS Q2Q%49.67%
EPS Next Y41.11%
EPS Next 2Y26.87%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)32.27%
Revenue growth 3Y17.96%
Revenue growth 5Y13.84%
Sales Q2Q%69.54%
Revenue Next Year61.9%
Revenue Next 2Y30.84%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y32.52%
EBIT growth 3Y5.86%
EBIT growth 5Y8.74%
EBIT Next Year153.94%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-28.84%
FCF growth 3Y-3.22%
FCF growth 5Y5.61%
OCF growth 1Y-25.18%
OCF growth 3Y-1.95%
OCF growth 5Y4.72%